Studies of HIV-1 envelope glycoprotein-mediated fusion using a simple fluorescence assay

AIDS

Volumn 10, Issue 3, 1996, Pages 241-246

  Weiss, Carol D ^a,c   Barnett, Susan W ^a,d   Cacalano, Nicholas ^b   Killeen, Nigel ^b   Littman, Dan R ^b,e   White, Judith M ^a,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^d NOVARTIS PHARMA AG   (Switzerland)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Envelope glycoprotein; Fluorescent dyes; HIV entry; Membrane fusion

Indexed keywords

CD4 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; GLYCOSYLPHOSPHATIDYLINOSITOL; VIRUS ENVELOPE PROTEIN;

ADHERENT CELL; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL FUSION; CELL STRAIN 3T3; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MEMBRANE FUSION; MEMBRANE MARKER; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; T LYMPHOCYTE;

EID: 0029864284     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199603000-00001     Document Type: Article

References (39)

1. Kowalski M, Potz J, Basiripour L, et al.: Functional regions of the envelope glycoprolein of human immunodeficiency virus type 1. Science 1987, 237:1351-1355.
2. Gallaher WR: Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus. Cell 1987, 50:327-328.
3. Gonzalez-Scarano F, Waxham MN, Ross AM, Hoxie JA: Sequence similarities between human immunodeficiency virus gp41 and paramyxovirus fusion proteins. AIDS Res Hum Retroviruses 1987, 3:245-252.
4. Bosch ML, Earl PL, Fargnoli K, Picciafuoco S, Giombini F, Wong-Stahl F, Franchini G: Identification of the fusion peptide of primate immunodeficiency viruses. Science 1989, 244:694-697.
5. Freed EO, Myers DJ, Risser R: Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41. Proc Natl Acad Sci USA 1990, 87:4650-4654.
6. Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA: The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984, 312:763-767.
7. Klatzmann D, Champagne E, Chamaret S, et al.: T-lymphocyle T4 molecule behaves as receptor for human retrovirus LAV. Nature 1984. 312:767-778.
8. McDougal JS, Kennedy MS, Sligh JM, Cort SP, Mawle A, Nicholson JKA: Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. Science 1986, 231:382-385.
9. McCune JM, Rabin B, Feinberg MB, et al.: Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell 1988, 53:55-67.
10. Sattentau QJ, Moore JP: Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J Exp Med 1991, 174:407-415.
11. McKeating JA, Cordell J, Dean CJ, Balte P: Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type 1 gp120. Virology 1992, 191:732-742.
12. Sattentau QJ, Moore JP, Vignauz F, Traincard F, Poignard P: Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J Virol 1993, 67:7383-7393.
13. Weiss CD, White JM: Characterization of stable Chinese hamster ovary cells expressing wild-type, secreted, and glycosylphosphatidylinositol-anchored human immunodeficiency virus type 1 envelope glycoprotein. J Virol 1993, 67:7060-7066.
14. Killeen N, Sawada S, Littman DR: Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4. EMBO J 1993, 12:1547-1553.
15. Castro BA, Weiss CD, Wiviott LD, Levy JA: Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells. J Clin Microbiol 1988, 26:2371-2376.
16. Hope TJ, McDonald D, Huang XJ, Low J, Parslow TG: Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: essential residues near the amino terminus. J Virol 1990, 64:5360-5366.
17. Brodsky MH, Warton M, Myers RM, Littman DR: Analysis of the site in CD4 that binds to the HIV envelope glycoprotein. J Immunol 1990, 144:3078-3086.
18. Kemble GW, Danieli T, White JM: GPI-anchored influenza hemagglutinin mediates lipid, but not content, mixing: Implications for the fusion mechanism. Cell 1994, 76:383-391.
19. Dimitrov DS, Golding H, Blumenthal R: Initial stages of HIV-1 envelope glycoprotein-mediated cell fusion monitored by a new assay based on redistribution of fluorescent dyes. AIDS Res Hum Retroviruses 1991, 7:799-805.
20. Frey S, Marsh M, Gunther S, et al.: Temperature dependence of cell-cell fusion induced by the envelope glycoprotein of human immunodeficiency virus type 1. J Virol 1995, 69:1462-1472.
21. Evans LA, Moreau J, Odehouri K, et al.: Characterization of a noncytopathic HIV-2 strain with unusual effects on CD4 expression. Science 1988, 240:1522-1525.
22. Gething M-J, Doms RW, York D, White JM: Studies on the mechanism of membrane fusion: site-specific mutagenesis of the hemagglutinin of influenza virus. J Cell Biol 1986, 102:11-23.
23. Salzwedel K, Johnston PB, Roberts SJ, Dubay JW, Hunter E: Expression and characterization of glycophospholipid-anchored human immunodeficiency virus type 1 envelope glycoproteins. J Virol 1993, 67:5279-5288.
24. Maddon P, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R: The T4 gene encodes the AIDS receptor and is expressed in the immune system and the brain. Cell 1986, 47:333-348.
25. Dragic T, Charneau P, Clavel F, Alizon M: Complementation of murine cells for human immunodeficiency virus envelope/CD4-mediated fusion in human/murine heterokaryons. J Virol 1992, 67:2355-2359.
26. Broder CC, Dimitrov DS, Blumenthal R, Berger EA: The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s). Virology 1993, 193:483-491.
27. Harrington RD, Geballe AP: Co-factor requirement for human immunodeficiency virus type 1 entry into a CD4-expressing human cell line. J Virol 1993, 67:5939-5947.
28. Callebaut C, Krust B, Jacotot E, Hovanessian AG: T cell activation antigen CD26 as a cofactor for entry of HIV in CD4+ cells. Science 1994, 262:2045-2050.
29. Alizon M, Dragic T: CD26 Antigen and HIV Fusion? Science 1994, 264:1161-1162.
30. Broder C, Nussbaum O, Gutheil WG, Bachovchin WW, Berger EA: CD26 Antigen and HIV Fusion? Science 1994, 264:1156-1159.
31. Callebaut C, Jaroto E, Krust B, Hovanessian AG: CD26 Antigen and HIV Fusion? Science 1994, 264:1162-1165.
32. Camerini D, Planelles V, Chen ISY: CD26 Antigen and HIV Fusion? Science 1994, 264:1160-1161.
33. Patience C, McKnight A, Clapham PR, Boyd MT, Weiss RA, Schulz TF: CD26 and HIV Fusion? Science 1994. 264:1159-1160.
34. Lazaro I, Naniche D, Signoret N, et al.: Factors involved in entry of the human immunodeficiency virus type 1 into permissive cells: lack of evidence of a role for CD26. J Virol 1994, 68:6535-6546.
35. Stamatatos L, Levy JA: CD26 is not involved in infection of peripheral blood mononuclear celly by HIV-1. AIDS 1994, 8:1727-1728.
36. Oravecz T, Roderiquez G, Koffi J, et al.: CD26 expression correlates with entry, replication and cytopathicity of monocytotropic HIV-1 strains in a T-cell line. Nature Med 1995, 1:919-926.
37. Dalgleish A: HIV and CD26. Nature Med 1995, 1:881-882.
38. Ciminale V, Felber BK, Campbell M, Pavlakis GN: A bioassay for HIV-1 based on Env-CD4 interaction. AIDS Res Hum Retroviruses 1990, 6:1281-1287.
39. Nussbaum O, Broder CC, Berger EA: Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. J Virol 1994, 68:5411-5422.